An update on the management of urinary tract infections in the era of antimicrobial resistance

MS Bader, M Loeb, AA Brooks - Postgraduate medicine, 2017 - Taylor & Francis
Urinary tract infections (UTIs) caused by antibiotic-resistant Gram-negative bacteria are a
growing concern due to limited therapeutic options. Gram-negative bacteria, specifically …

The problem of carbapenemase-producing-carbapenem-resistant-Enterobacteriaceae detection

JD Lutgring, BM Limbago - Journal of clinical microbiology, 2016 - Am Soc Microbiol
The emergence and spread of carbapenemase-producing carbapenem-resistant
Enterobacteriaceae (CP-CRE) are a significant clinical and public health concern. Reliable …

[HTML][HTML] Drug-driven phenotypic convergence supports rational treatment strategies of chronic infections

L Imamovic, MMH Ellabaan, AMD Machado, L Citterio… - Cell, 2018 - cell.com
Chronic Pseudomonas aeruginosa infections evade antibiotic therapy and are associated
with mortality in cystic fibrosis (CF) patients. We find that in vitro resistance evolution of P …

Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician

N Martis, S Leroy, V Blanc - Journal of Infection, 2014 - Elsevier
Antimicrobial resistance to Pseudomonas aeruginosa is on the rise. In the absence of new
anti-pseudomonal drugs, clinicians have had to resort to older antimicrobials such as colistin …

Prolonging β-lactam infusion: a review of the rationale and evidence, and guidance for implementation

SH MacVane, JL Kuti, DP Nicolau - International journal of antimicrobial …, 2014 - Elsevier
Given the sparse antibiotic pipeline and the increasing prevalence of resistant organisms,
efforts should be made to optimise the pharmacodynamic exposure of currently available …

[HTML][HTML] Treatment of bloodstream infections in ICUs

JF Timsit, JF Soubirou, G Voiriot, S Chemam… - BMC infectious …, 2014 - Springer
Bloodstream infections (BSIs) are frequent in ICU and is a prognostic factor of severe sepsis.
Community acquired BSIs usually due to susceptible bacteria should be clearly …

Clinical and bacterial risk factors for mortality in children with carbapenem-resistant Enterobacteriaceae bloodstream infections in India

LEB Nabarro, C Shankar, AK Pragasam… - The Pediatric …, 2017 - journals.lww.com
Background: Carbapenem-resistant Enterobacteriaceae (CRE) are an increasing cause of
nosocomial infection in hospitalized children worldwide. Few studies have investigated risk …

Continuous and prolonged intravenous β-lactam dosing: implications for the clinical laboratory

M Grupper, JL Kuti, DP Nicolau - Clinical microbiology reviews, 2016 - Am Soc Microbiol
Beta-lactam antibiotics serve as a cornerstone in the management of bacterial infections
because of their wide spectrum of activity and low toxicity. Since resistance rates among …

Defining clinical exposures of cefepime for gram-negative bloodstream infections that are associated with improved survival

NJ Rhodes, JL Kuti, DP Nicolau… - Antimicrobial agents …, 2016 - Am Soc Microbiol
The percentage of time that free drug concentrations remain above the MIC (f T> MIC) that is
necessary to prevent mortality among cefepime-treated patients with Gram-negative …

Clinical outcomes of Enterobacteriaceae infections stratified by carbapenem MICs

TS Patel, JL Nagel - Journal of clinical microbiology, 2015 - Am Soc Microbiol
ABSTRACT The Clinical and Laboratory Standards Institute (CLSI) lowered the MIC
breakpoints for meropenem and imipenem from 4 mg/liter to 1 mg/liter for …